Hutch News
Results per Page:
Investment in business development pays dividends for research, patients
Fred Hutch tech transfer specialists help scientists navigate path to bringing innovations to patients
Location, location, location: therapeutic T cells traffic to HIV reservoirs
From the Kiem Lab, Clinical Research Division
If at first you don’t succeed: Testing outcomes of second CAR T-cell infusions
From the Turtle group and collaborators, Clinical Research Division
T cells recognize novel cancer-specific antigen derived from leukemic gene fusion
From the Bleakley lab, Clinical Research Division
WT1 T-cell Receptor Transduced T cells prevent AML relapse
From the Chapuis and Greenberg Labs, Clinical Research Division
Nanoparticles open doors to cancer-fighting CAR T cells
Tiny liposome-based drug carriers make tumors more vulnerable to targeted immunotherapy
Immunotherapy strategy for ovarian cancer aims to rewire a ‘kill switch’ to ramp-up signal
T cells bearing a new engineered protein boost immunotherapy’s effectiveness in laboratory models of AML, ovarian, pancreatic cancers
New insights into CAR T-cell therapy's potential side effects
Detailed study of cytokine release syndrome and neurologic toxicities could help make emerging cancer immunotherapies safer
Dissolving implant could bring immunotherapy to solid tumors
A biopolymer sponge delivers cancer-shrinking T-cell therapy in preclinical study
Tiny tech reprograms immune cells to fight cancer
Nanoparticles turn immune cells into leukemia-fighting powerhouses while they’re still inside the body
Immunotherapy for ovarian cancer shows promise in mouse model, but hurdles remain
‘Tumor microenvironment’ poses unique challenges for T-cell therapy in solid tumors
What's new in blood diseases
Four things to watch from the 2016 annual meeting of the American Society of Hematology
Fred Hutch opens first-of-its kind Bezos Family Immunotherapy Clinic
Clinic will allow researchers to conduct twice as many immunotherapy trials, enable intensive patient monitoring to improve experimental therapies
Good News at Fred Hutch
Celebrating faculty and staff achievements
Fred Hutch at ASCO
Research highlights from the annual meeting of the American Society of Clinical Oncology
The right tools for the job: taking immunotherapy to the next level
Dr. Matthias Stephan is combining the fields of immunology, bioengineering and gene therapy to harness the immune system to treat solid tumors
'A tidal wave coming': Xconomy Forum focuses on promising treatments
Immunotherapy a key topic at sold-out discussion on the role of biotech in Seattle
Immunotherapy offers 'new era' for cancer patients
Dr. Stan Riddell wows Science for Life attendees with overview of one of the most promising areas of medical research
Fred Hutch recruits D. Gary Gilliland as its new president and director
Internationally renowned cancer genetics expert to take the helm in the new year
NCI awards $11.5 million to Fred Hutchinson Cancer Research Center to lead breast cancer research consortium
Projects include developing targeted therapies to treat drug-resistant tumors